Glycosylation-independent Lysosomal Targeting of Acid α-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice

被引:86
作者
Maga, John A. [1 ]
Zhou, Jianghong [1 ]
Kambampati, Ravi [1 ]
Peng, Susan [1 ]
Wang, Xu [2 ]
Bohnsack, Richard N. [3 ]
Thomm, Angela [1 ]
Golata, Sarah [1 ]
Tom, Peggy [1 ]
Dahms, Nancy M. [3 ]
Byrne, Barry J. [2 ]
LeBowitz, Jonathan H. [1 ]
机构
[1] ZyStor Therapeut, Milwaukee, WI 53226 USA
[2] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA
[3] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
关键词
MANNOSE 6-PHOSPHATE RECEPTOR; II BINDING-SITE; ALGLUCOSIDASE ALPHA; MOUSE MODEL; INSULIN; STORAGE; RECOMBINANT; DISEASE; INFANTILE; ENZYME;
D O I
10.1074/jbc.M112.438663
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have used a peptide-based targeting system to improve lysosomal delivery of acid alpha-glucosidase (GAA), the enzyme deficient in patients with Pompe disease. Human GAA was fused to the glycosylation-independent lysosomal targeting (GILT) tag, which contains a portion of insulin-like growth factor II, to create an active, chimeric enzyme with high affinity for the cation-independent mannose 6-phosphate receptor. GILT-tagged GAA was taken up by L6 myoblasts about 25-fold more efficiently than was recombinant human GAA (rhGAA). Once delivered to the lysosome, the mature form of GILT-tagged-GAA was indistinguishable from rhGAA and persisted with a half-life indistinguishable from rhGAA. GILT-tagged GAA was significantly more effective than rhGAA in clearing glycogen from numerous skeletal muscle tissues in the Pompe mouse model. The GILT-tagged GAA enzyme may provide an improved enzyme replacement therapy for Pompe disease patients.
引用
收藏
页码:1428 / 1438
页数:11
相关论文
共 41 条
[1]   Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II:: Results of a phase I/II clinical trial [J].
Amalfitano, A ;
Bengur, AR ;
Morse, RP ;
Majure, JM ;
Case, LE ;
Veerling, DL ;
Mackey, J ;
Kishnani, P ;
Smith, W ;
McVie-Wylie, A ;
Sullivan, JA ;
Hoganson, GE ;
Phillips, JA ;
Schaefer, GB ;
Charrow, J ;
Ware, RE ;
Bossen, EH ;
Chen, YT .
GENETICS IN MEDICINE, 2001, 3 (02) :132-138
[2]   IMPROVED SILVER STAINING OF PLANT-PROTEINS, RNA AND DNA IN POLYACRYLAMIDE GELS [J].
BLUM, H ;
BEIER, H ;
GROSS, HJ .
ELECTROPHORESIS, 1987, 8 (02) :93-99
[3]   REGULATION OF THE MANNOSE-6-PHOSPHATE IGF-II RECEPTOR EXPRESSION AT THE CELL-SURFACE BY MANNOSE-6-PHOSPHATE, INSULIN-LIKE GROWTH-FACTORS AND EPIDERMAL GROWTH-FACTOR [J].
BRAULKE, T ;
TIPPMER, S ;
NEHER, E ;
VONFIGURA, K .
EMBO JOURNAL, 1989, 8 (03) :681-686
[4]  
Bremel R. D., 2005, U. S. Patent, Patent No. 6852510
[5]   SIMULTANEOUS ABSENCE OF ALPHA-1,4-GLUCOSIDASE AND ALPHA-1,6-GLUCOSIDASE ACTIVITIES (PH 4) IN TISSUES OF CHILDREN WITH TYPE 2 GLYCOGEN STORAGE DISEASE [J].
BROWN, BI ;
BROWN, DH ;
JEFFREY, PL .
BIOCHEMISTRY, 1970, 9 (06) :1423-&
[6]   LYSOSOME-ASSOCIATED MEMBRANE-PROTEINS - CHARACTERIZATION OF LAMP-1 OF MACROPHAGE-P388 AND MOUSE EMBRYO 3T3 CULTURED-CELLS [J].
CHEN, JW ;
PAN, W ;
DSOUZA, MP ;
AUGUST, JT .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1985, 239 (02) :574-586
[7]   P-type lectins [J].
Dahms, NM ;
Hancock, MK .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2002, 1572 (2-3) :317-340
[8]   Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease [J].
Fukuda, T ;
Ewan, L ;
Bauer, M ;
Mattaliano, RJ ;
Zaal, K ;
Ralston, E ;
Plotz, PH ;
Raben, N .
ANNALS OF NEUROLOGY, 2006, 59 (04) :700-708
[9]   Truncated forms of the insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor encompassing the IGF-II binding site: Characterization of a point mutation that abolishes IGF-II binding [J].
Garmroudi, F ;
Devi, G ;
Slentz, DH ;
Schaffer, BS ;
MacDonald, RG .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (06) :642-651